Activist investor Carl Icahn has stepped down from his informal advisory role on regulatory reform to President Donald Trump, he said on Friday.
Jim Cramer's take on stocks of interest to viewers includes positive comments on Berkshire Hathaway.
Best Buy's outstanding results show that investors are still getting it wrong and creating opportunities for others.
Carl Icahn exited his positions in Allergan and Nuance Communications during the first quarter of the year and acquired a stake in a Xerox spinoff after pressuring for a split.
Democratic lawmakers step up their campaign against Icahn, charging that the White House's designated agency ethics official previously provided paid legal services to the billionaire adviser to the Trump Administration.